Quality evaluation of commercially available healthcare applications for prostate cancer management

被引：0
作者：
Bouarroudj, Kenza [1 ]
Kitouni, Ilham [2 ]
Lechekhab, Abdelmouhsen [3 ]
Leghelimi, Zinelabidine [3 ]
Kara, Issam
机构：
[1] Abdelhamid Mehri Constantine 2 Univ, MISC Lab, Constantine, Algeria
[2] Abdelhamid Mehri Constantine 2 Univ, LISIA Lab, Constantine, Algeria
[3] Abdelhamid Mehri Constantine 2 Univ, Constantine, Algeria
来源：
MULTIMEDIA TOOLS AND APPLICATIONS | 2023年 / 82卷 / 20期
关键词：
Prostate cancer; Artificial intelligence; MARS; HAs; RADIOTHERAPY;
D O I：
10.1007/s11042-023-15601-9
中图分类号：
TP [自动化技术、计算机技术];
学科分类号：
0812 ;
摘要：
Many prostate cancer health applications are available on the software market. The main software solutions focus on helping patients cope with prostate cancer, helping urologists manage medical records and helping radiologists interpret multi-parametric magnetic resonance imaging. Some of these applications for prostate cancer make use of artificial intelligence. It is believed that artificial intelligence will play a key role in facilitating the clinical practice of health professionals and providing psychological support to patients. This study aims to assess the quality of commercially available applications for prostate cancer management.
引用
收藏
页码：31793 / 31819
页数：27
相关论文
共 50 条
  • [41] Prostate cancer pain management: EAU guidelines on pain management
    Pia Bader
    Dieter Echtle
    Valerie Fonteyne
    Kostas Livadas
    Gert De Meerleer
    Alvaro Paez Borda
    Eleni G. Papaioannou
    Jan H. Vranken
    World Journal of Urology, 2012, 30 : 677 - 686
  • [42] A Cost-Effectiveness and Quality of Life Analysis of Different Approaches to the Management and Treatment of Localized Prostate Cancer
    Harat, Aleksandra
    Harat, Maciej
    Martinson, Melissa
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [43] Evaluation of data quality in the National Prostate Cancer Register of Sweden (Reprinted)
    Tomic, Katarina
    Sandin, Fredrik
    Wigertz, Annette
    Robinson, David
    Lambe, Mats
    Stattin, Par
    EUROPEAN JOURNAL OF CANCER, 2015, 51 (09) : 1130 - 1130
  • [44] Management of patients with hormone refractory prostate cancer
    Muthuramalingam, SR
    Patel, K
    Protheroe, A
    CLINICAL ONCOLOGY, 2004, 16 (08) : 505 - 516
  • [45] Pharmacoeconomics of Available Treatment Options for Metastatic Prostate Cancer
    Steven B. Zeliadt
    David F. Penson
    PharmacoEconomics, 2007, 25 : 309 - 327
  • [46] Comprehensive evaluation and clinical implementation of commercially available Monte Carlo dose calculation algorithm
    Zhang, Aizhen
    Wen, Ning
    Nurushev, Teamour
    Burmeister, Jay
    Chetty, Indrin J.
    JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2013, 14 (02): : 127 - 145
  • [47] Transurethral resection of the prostate after radiotherapy for prostate cancer: Impact on quality of life
    Pinkawa, Michael
    Klotz, Jens
    Djukic, Victoria
    Petz, Dalma
    Holy, Richard
    Eble, Michael J.
    INTERNATIONAL JOURNAL OF UROLOGY, 2014, 21 (09) : 899 - 903
  • [48] Quality assessment in prostate cancer centers certified by the German Cancer Society
    Kowalski, Christoph
    Ferencz, Julia
    Albers, Peter
    Fichtner, Jan
    Wiegel, Thomas
    Feick, Guenter
    Wesselmann, Simone
    WORLD JOURNAL OF UROLOGY, 2016, 34 (05) : 665 - 672
  • [49] Clustering of prostate cancer healthcare pathways in the French National Healthcare database
    Baulain, Romeo
    Jove, Jeremy
    Sakr, Dunia
    Gross-Goupil, Marine
    Rouyer, Magali
    Puel, Marius
    Blin, Patrick
    Droz-Perroteau, Cecile
    Lassalle, Regis
    Thurin, Nicolas H.
    CANCER INNOVATION, 2023, 2 (01): : 52 - 64
  • [50] Survivorship and Improving Quality of Life in Men with Prostate Cancer
    Bourke, Liam
    Boorjian, Stephen A.
    Briganti, Alberto
    Klotz, Laurence
    Mucci, Lorelei
    Resnick, Matthew J.
    Rosario, Derek J.
    Skolarus, Ted A.
    Penson, David F.
    EUROPEAN UROLOGY, 2015, 68 (03) : 374 - 383
12345